Global Cancer Genome Analysis Market Insights, Forecast to 2029
This report presents an overview of global market for Cancer Genome Analysis market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Cancer Genome Analysis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Genome Analysis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Genome Analysis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cancer Genome Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cancer Genome Analysis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd. and Anchor Dx, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Genome Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genome Analysis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Genome Analysis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Cancer Genome Analysis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Genome Analysis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Genome Analysis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cancer Genome Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cancer Genome Analysis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd. and Anchor Dx, etc.
By Company
- Abbott Diagnostics
- AccuraGen Inc
- Acuamark Diagnostics
- Admera Health, LLC
- Agena Bioscience, Inc
- Agilent
- Almac Diagnostics
- Amoy Diagnostics Co., Ltd.
- Anchor Dx
- ANGLE plc
- ApoCell, Inc.
- ArcherDx, Inc
- Asuragen
- AVIVA Biosciences
- Baylor Miraca Genetics Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- BGI Genomics Co. Ltd
- Bioarray Genetics
- Biocartis
- Biocept, Inc
- Biodesix Inc
- BioFluidica
- bioMйrieux Diagnostics
- Bioneer Corporation
- Bio-Rad Laboratories, Inc
- Bio-Techne
- Solid Tissue Analysis
- Liquid Tissue Analysis
- Clinical
- Pharmaceutical
- Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Genome Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genome Analysis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Genome Analysis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Analysis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Solid Tissue Analysis
1.2.3 Liquid Tissue Analysis
1.3 Market by Application
1.3.1 Global Cancer Genome Analysis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical
1.3.3 Pharmaceutical
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cancer Genome Analysis Market Perspective (2018-2029)
2.2 Global Cancer Genome Analysis Growth Trends by Region
2.2.1 Cancer Genome Analysis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Genome Analysis Historic Market Size by Region (2018-2023)
2.2.3 Cancer Genome Analysis Forecasted Market Size by Region (2024-2029)
2.3 Cancer Genome Analysis Market Dynamics
2.3.1 Cancer Genome Analysis Industry Trends
2.3.2 Cancer Genome Analysis Market Drivers
2.3.3 Cancer Genome Analysis Market Challenges
2.3.4 Cancer Genome Analysis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Cancer Genome Analysis by Players
3.1.1 Global Cancer Genome Analysis Revenue by Players (2018-2023)
3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Genome Analysis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Genome Analysis Market Concentration Ratio
3.4.1 Global Cancer Genome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Analysis Revenue in 2022
3.5 Global Key Players of Cancer Genome Analysis Head office and Area Served
3.6 Global Key Players of Cancer Genome Analysis, Product and Application
3.7 Global Key Players of Cancer Genome Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CANCER GENOME ANALYSIS BREAKDOWN DATA BY TYPE
4.1 Global Cancer Genome Analysis Historic Market Size by Type (2018-2023)
4.2 Global Cancer Genome Analysis Forecasted Market Size by Type (2024-2029)
5 CANCER GENOME ANALYSIS BREAKDOWN DATA BY APPLICATION
5.1 Global Cancer Genome Analysis Historic Market Size by Application (2018-2023)
5.2 Global Cancer Genome Analysis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cancer Genome Analysis Market Size (2018-2029)
6.2 North America Cancer Genome Analysis Market Size by Type
6.2.1 North America Cancer Genome Analysis Market Size by Type (2018-2023)
6.2.2 North America Cancer Genome Analysis Market Size by Type (2024-2029)
6.2.3 North America Cancer Genome Analysis Market Share by Type (2018-2029)
6.3 North America Cancer Genome Analysis Market Size by Application
6.3.1 North America Cancer Genome Analysis Market Size by Application (2018-2023)
6.3.2 North America Cancer Genome Analysis Market Size by Application (2024-2029)
6.3.3 North America Cancer Genome Analysis Market Share by Application (2018-2029)
6.4 North America Cancer Genome Analysis Market Size by Country
6.4.1 North America Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cancer Genome Analysis Market Size by Country (2018-2023)
6.4.3 North America Cancer Genome Analysis Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Cancer Genome Analysis Market Size (2018-2029)
7.2 Europe Cancer Genome Analysis Market Size by Type
7.2.1 Europe Cancer Genome Analysis Market Size by Type (2018-2023)
7.2.2 Europe Cancer Genome Analysis Market Size by Type (2024-2029)
7.2.3 Europe Cancer Genome Analysis Market Share by Type (2018-2029)
7.3 Europe Cancer Genome Analysis Market Size by Application
7.3.1 Europe Cancer Genome Analysis Market Size by Application (2018-2023)
7.3.2 Europe Cancer Genome Analysis Market Size by Application (2024-2029)
7.3.3 Europe Cancer Genome Analysis Market Share by Application (2018-2029)
7.4 Europe Cancer Genome Analysis Market Size by Country
7.4.1 Europe Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cancer Genome Analysis Market Size by Country (2018-2023)
7.4.3 Europe Cancer Genome Analysis Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Cancer Genome Analysis Market Size (2018-2029)
8.2 China Cancer Genome Analysis Market Size by Type
8.2.1 China Cancer Genome Analysis Market Size by Type (2018-2023)
8.2.2 China Cancer Genome Analysis Market Size by Type (2024-2029)
8.2.3 China Cancer Genome Analysis Market Share by Type (2018-2029)
8.3 China Cancer Genome Analysis Market Size by Application
8.3.1 China Cancer Genome Analysis Market Size by Application (2018-2023)
8.3.2 China Cancer Genome Analysis Market Size by Application (2024-2029)
8.3.3 China Cancer Genome Analysis Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Cancer Genome Analysis Market Size (2018-2029)
9.2 Asia Cancer Genome Analysis Market Size by Type
9.2.1 Asia Cancer Genome Analysis Market Size by Type (2018-2023)
9.2.2 Asia Cancer Genome Analysis Market Size by Type (2024-2029)
9.2.3 Asia Cancer Genome Analysis Market Share by Type (2018-2029)
9.3 Asia Cancer Genome Analysis Market Size by Application
9.3.1 Asia Cancer Genome Analysis Market Size by Application (2018-2023)
9.3.2 Asia Cancer Genome Analysis Market Size by Application (2024-2029)
9.3.3 Asia Cancer Genome Analysis Market Share by Application (2018-2029)
9.4 Asia Cancer Genome Analysis Market Size by Region
9.4.1 Asia Cancer Genome Analysis Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cancer Genome Analysis Market Size by Region (2018-2023)
9.4.3 Asia Cancer Genome Analysis Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Cancer Genome Analysis Introduction
11.1.4 Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Developments
11.2 AccuraGen Inc
11.2.1 AccuraGen Inc Company Details
11.2.2 AccuraGen Inc Business Overview
11.2.3 AccuraGen Inc Cancer Genome Analysis Introduction
11.2.4 AccuraGen Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.2.5 AccuraGen Inc Recent Developments
11.3 Acuamark Diagnostics
11.3.1 Acuamark Diagnostics Company Details
11.3.2 Acuamark Diagnostics Business Overview
11.3.3 Acuamark Diagnostics Cancer Genome Analysis Introduction
11.3.4 Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.3.5 Acuamark Diagnostics Recent Developments
11.4 Admera Health, LLC
11.4.1 Admera Health, LLC Company Details
11.4.2 Admera Health, LLC Business Overview
11.4.3 Admera Health, LLC Cancer Genome Analysis Introduction
11.4.4 Admera Health, LLC Revenue in Cancer Genome Analysis Business (2018-2023)
11.4.5 Admera Health, LLC Recent Developments
11.5 Agena Bioscience, Inc
11.5.1 Agena Bioscience, Inc Company Details
11.5.2 Agena Bioscience, Inc Business Overview
11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Introduction
11.5.4 Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.5.5 Agena Bioscience, Inc Recent Developments
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Cancer Genome Analysis Introduction
11.6.4 Agilent Revenue in Cancer Genome Analysis Business (2018-2023)
11.6.5 Agilent Recent Developments
11.7 Almac Diagnostics
11.7.1 Almac Diagnostics Company Details
11.7.2 Almac Diagnostics Business Overview
11.7.3 Almac Diagnostics Cancer Genome Analysis Introduction
11.7.4 Almac Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.7.5 Almac Diagnostics Recent Developments
11.8 Amoy Diagnostics Co., Ltd.
11.8.1 Amoy Diagnostics Co., Ltd. Company Details
11.8.2 Amoy Diagnostics Co., Ltd. Business Overview
11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Introduction
11.8.4 Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2018-2023)
11.8.5 Amoy Diagnostics Co., Ltd. Recent Developments
11.9 Anchor Dx
11.9.1 Anchor Dx Company Details
11.9.2 Anchor Dx Business Overview
11.9.3 Anchor Dx Cancer Genome Analysis Introduction
11.9.4 Anchor Dx Revenue in Cancer Genome Analysis Business (2018-2023)
11.9.5 Anchor Dx Recent Developments
11.10 ANGLE plc
11.10.1 ANGLE plc Company Details
11.10.2 ANGLE plc Business Overview
11.10.3 ANGLE plc Cancer Genome Analysis Introduction
11.10.4 ANGLE plc Revenue in Cancer Genome Analysis Business (2018-2023)
11.10.5 ANGLE plc Recent Developments
11.11 ApoCell, Inc.
11.11.1 ApoCell, Inc. Company Details
11.11.2 ApoCell, Inc. Business Overview
11.11.3 ApoCell, Inc. Cancer Genome Analysis Introduction
11.11.4 ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2018-2023)
11.11.5 ApoCell, Inc. Recent Developments
11.12 ArcherDx, Inc
11.12.1 ArcherDx, Inc Company Details
11.12.2 ArcherDx, Inc Business Overview
11.12.3 ArcherDx, Inc Cancer Genome Analysis Introduction
11.12.4 ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.12.5 ArcherDx, Inc Recent Developments
11.13 Asuragen
11.13.1 Asuragen Company Details
11.13.2 Asuragen Business Overview
11.13.3 Asuragen Cancer Genome Analysis Introduction
11.13.4 Asuragen Revenue in Cancer Genome Analysis Business (2018-2023)
11.13.5 Asuragen Recent Developments
11.14 AVIVA Biosciences
11.14.1 AVIVA Biosciences Company Details
11.14.2 AVIVA Biosciences Business Overview
11.14.3 AVIVA Biosciences Cancer Genome Analysis Introduction
11.14.4 AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2018-2023)
11.14.5 AVIVA Biosciences Recent Developments
11.15 Baylor Miraca Genetics Laboratories
11.15.1 Baylor Miraca Genetics Laboratories Company Details
11.15.2 Baylor Miraca Genetics Laboratories Business Overview
11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Introduction
11.15.4 Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2018-2023)
11.15.5 Baylor Miraca Genetics Laboratories Recent Developments
11.16 Beckman Coulter, Inc.
11.16.1 Beckman Coulter, Inc. Company Details
11.16.2 Beckman Coulter, Inc. Business Overview
11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Introduction
11.16.4 Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2018-2023)
11.16.5 Beckman Coulter, Inc. Recent Developments
11.17 Becton, Dickinson and Company
11.17.1 Becton, Dickinson and Company Company Details
11.17.2 Becton, Dickinson and Company Business Overview
11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Introduction
11.17.4 Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2018-2023)
11.17.5 Becton, Dickinson and Company Recent Developments
11.18 BGI Genomics Co. Ltd
11.18.1 BGI Genomics Co. Ltd Company Details
11.18.2 BGI Genomics Co. Ltd Business Overview
11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Introduction
11.18.4 BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2018-2023)
11.18.5 BGI Genomics Co. Ltd Recent Developments
11.19 Bioarray Genetics
11.19.1 Bioarray Genetics Company Details
11.19.2 Bioarray Genetics Business Overview
11.19.3 Bioarray Genetics Cancer Genome Analysis Introduction
11.19.4 Bioarray Genetics Revenue in Cancer Genome Analysis Business (2018-2023)
11.19.5 Bioarray Genetics Recent Developments
11.20 Biocartis
11.20.1 Biocartis Company Details
11.20.2 Biocartis Business Overview
11.20.3 Biocartis Cancer Genome Analysis Introduction
11.20.4 Biocartis Revenue in Cancer Genome Analysis Business (2018-2023)
11.20.5 Biocartis Recent Developments
11.21 Biocept, Inc
11.21.1 Biocept, Inc Company Details
11.21.2 Biocept, Inc Business Overview
11.21.3 Biocept, Inc Cancer Genome Analysis Introduction
11.21.4 Biocept, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.21.5 Biocept, Inc Recent Developments
11.22 Biodesix Inc
11.22.1 Biodesix Inc Company Details
11.22.2 Biodesix Inc Business Overview
11.22.3 Biodesix Inc Cancer Genome Analysis Introduction
11.22.4 Biodesix Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.22.5 Biodesix Inc Recent Developments
11.23 BioFluidica
11.23.1 BioFluidica Company Details
11.23.2 BioFluidica Business Overview
11.23.3 BioFluidica Cancer Genome Analysis Introduction
11.23.4 BioFluidica Revenue in Cancer Genome Analysis Business (2018-2023)
11.23.5 BioFluidica Recent Developments
11.24 bioMйrieux Diagnostics
11.24.1 bioMйrieux Diagnostics Company Details
11.24.2 bioMйrieux Diagnostics Business Overview
11.24.3 bioMйrieux Diagnostics Cancer Genome Analysis Introduction
11.24.4 bioMйrieux Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.24.5 bioMйrieux Diagnostics Recent Developments
11.25 Bioneer Corporation
11.25.1 Bioneer Corporation Company Details
11.25.2 Bioneer Corporation Business Overview
11.25.3 Bioneer Corporation Cancer Genome Analysis Introduction
11.25.4 Bioneer Corporation Revenue in Cancer Genome Analysis Business (2018-2023)
11.25.5 Bioneer Corporation Recent Developments
11.26 Bio-Rad Laboratories, Inc
11.26.1 Bio-Rad Laboratories, Inc Company Details
11.26.2 Bio-Rad Laboratories, Inc Business Overview
11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Introduction
11.26.4 Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.26.5 Bio-Rad Laboratories, Inc Recent Developments
11.27 Bio-Techne
11.27.1 Bio-Techne Company Details
11.27.2 Bio-Techne Business Overview
11.27.3 Bio-Techne Cancer Genome Analysis Introduction
11.27.4 Bio-Techne Revenue in Cancer Genome Analysis Business (2018-2023)
11.27.5 Bio-Techne Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Analysis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Solid Tissue Analysis
1.2.3 Liquid Tissue Analysis
1.3 Market by Application
1.3.1 Global Cancer Genome Analysis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical
1.3.3 Pharmaceutical
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cancer Genome Analysis Market Perspective (2018-2029)
2.2 Global Cancer Genome Analysis Growth Trends by Region
2.2.1 Cancer Genome Analysis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Genome Analysis Historic Market Size by Region (2018-2023)
2.2.3 Cancer Genome Analysis Forecasted Market Size by Region (2024-2029)
2.3 Cancer Genome Analysis Market Dynamics
2.3.1 Cancer Genome Analysis Industry Trends
2.3.2 Cancer Genome Analysis Market Drivers
2.3.3 Cancer Genome Analysis Market Challenges
2.3.4 Cancer Genome Analysis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Cancer Genome Analysis by Players
3.1.1 Global Cancer Genome Analysis Revenue by Players (2018-2023)
3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Genome Analysis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Genome Analysis Market Concentration Ratio
3.4.1 Global Cancer Genome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Analysis Revenue in 2022
3.5 Global Key Players of Cancer Genome Analysis Head office and Area Served
3.6 Global Key Players of Cancer Genome Analysis, Product and Application
3.7 Global Key Players of Cancer Genome Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CANCER GENOME ANALYSIS BREAKDOWN DATA BY TYPE
4.1 Global Cancer Genome Analysis Historic Market Size by Type (2018-2023)
4.2 Global Cancer Genome Analysis Forecasted Market Size by Type (2024-2029)
5 CANCER GENOME ANALYSIS BREAKDOWN DATA BY APPLICATION
5.1 Global Cancer Genome Analysis Historic Market Size by Application (2018-2023)
5.2 Global Cancer Genome Analysis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cancer Genome Analysis Market Size (2018-2029)
6.2 North America Cancer Genome Analysis Market Size by Type
6.2.1 North America Cancer Genome Analysis Market Size by Type (2018-2023)
6.2.2 North America Cancer Genome Analysis Market Size by Type (2024-2029)
6.2.3 North America Cancer Genome Analysis Market Share by Type (2018-2029)
6.3 North America Cancer Genome Analysis Market Size by Application
6.3.1 North America Cancer Genome Analysis Market Size by Application (2018-2023)
6.3.2 North America Cancer Genome Analysis Market Size by Application (2024-2029)
6.3.3 North America Cancer Genome Analysis Market Share by Application (2018-2029)
6.4 North America Cancer Genome Analysis Market Size by Country
6.4.1 North America Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cancer Genome Analysis Market Size by Country (2018-2023)
6.4.3 North America Cancer Genome Analysis Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Cancer Genome Analysis Market Size (2018-2029)
7.2 Europe Cancer Genome Analysis Market Size by Type
7.2.1 Europe Cancer Genome Analysis Market Size by Type (2018-2023)
7.2.2 Europe Cancer Genome Analysis Market Size by Type (2024-2029)
7.2.3 Europe Cancer Genome Analysis Market Share by Type (2018-2029)
7.3 Europe Cancer Genome Analysis Market Size by Application
7.3.1 Europe Cancer Genome Analysis Market Size by Application (2018-2023)
7.3.2 Europe Cancer Genome Analysis Market Size by Application (2024-2029)
7.3.3 Europe Cancer Genome Analysis Market Share by Application (2018-2029)
7.4 Europe Cancer Genome Analysis Market Size by Country
7.4.1 Europe Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cancer Genome Analysis Market Size by Country (2018-2023)
7.4.3 Europe Cancer Genome Analysis Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Cancer Genome Analysis Market Size (2018-2029)
8.2 China Cancer Genome Analysis Market Size by Type
8.2.1 China Cancer Genome Analysis Market Size by Type (2018-2023)
8.2.2 China Cancer Genome Analysis Market Size by Type (2024-2029)
8.2.3 China Cancer Genome Analysis Market Share by Type (2018-2029)
8.3 China Cancer Genome Analysis Market Size by Application
8.3.1 China Cancer Genome Analysis Market Size by Application (2018-2023)
8.3.2 China Cancer Genome Analysis Market Size by Application (2024-2029)
8.3.3 China Cancer Genome Analysis Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Cancer Genome Analysis Market Size (2018-2029)
9.2 Asia Cancer Genome Analysis Market Size by Type
9.2.1 Asia Cancer Genome Analysis Market Size by Type (2018-2023)
9.2.2 Asia Cancer Genome Analysis Market Size by Type (2024-2029)
9.2.3 Asia Cancer Genome Analysis Market Share by Type (2018-2029)
9.3 Asia Cancer Genome Analysis Market Size by Application
9.3.1 Asia Cancer Genome Analysis Market Size by Application (2018-2023)
9.3.2 Asia Cancer Genome Analysis Market Size by Application (2024-2029)
9.3.3 Asia Cancer Genome Analysis Market Share by Application (2018-2029)
9.4 Asia Cancer Genome Analysis Market Size by Region
9.4.1 Asia Cancer Genome Analysis Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cancer Genome Analysis Market Size by Region (2018-2023)
9.4.3 Asia Cancer Genome Analysis Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Cancer Genome Analysis Introduction
11.1.4 Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Developments
11.2 AccuraGen Inc
11.2.1 AccuraGen Inc Company Details
11.2.2 AccuraGen Inc Business Overview
11.2.3 AccuraGen Inc Cancer Genome Analysis Introduction
11.2.4 AccuraGen Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.2.5 AccuraGen Inc Recent Developments
11.3 Acuamark Diagnostics
11.3.1 Acuamark Diagnostics Company Details
11.3.2 Acuamark Diagnostics Business Overview
11.3.3 Acuamark Diagnostics Cancer Genome Analysis Introduction
11.3.4 Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.3.5 Acuamark Diagnostics Recent Developments
11.4 Admera Health, LLC
11.4.1 Admera Health, LLC Company Details
11.4.2 Admera Health, LLC Business Overview
11.4.3 Admera Health, LLC Cancer Genome Analysis Introduction
11.4.4 Admera Health, LLC Revenue in Cancer Genome Analysis Business (2018-2023)
11.4.5 Admera Health, LLC Recent Developments
11.5 Agena Bioscience, Inc
11.5.1 Agena Bioscience, Inc Company Details
11.5.2 Agena Bioscience, Inc Business Overview
11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Introduction
11.5.4 Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.5.5 Agena Bioscience, Inc Recent Developments
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Cancer Genome Analysis Introduction
11.6.4 Agilent Revenue in Cancer Genome Analysis Business (2018-2023)
11.6.5 Agilent Recent Developments
11.7 Almac Diagnostics
11.7.1 Almac Diagnostics Company Details
11.7.2 Almac Diagnostics Business Overview
11.7.3 Almac Diagnostics Cancer Genome Analysis Introduction
11.7.4 Almac Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.7.5 Almac Diagnostics Recent Developments
11.8 Amoy Diagnostics Co., Ltd.
11.8.1 Amoy Diagnostics Co., Ltd. Company Details
11.8.2 Amoy Diagnostics Co., Ltd. Business Overview
11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Introduction
11.8.4 Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2018-2023)
11.8.5 Amoy Diagnostics Co., Ltd. Recent Developments
11.9 Anchor Dx
11.9.1 Anchor Dx Company Details
11.9.2 Anchor Dx Business Overview
11.9.3 Anchor Dx Cancer Genome Analysis Introduction
11.9.4 Anchor Dx Revenue in Cancer Genome Analysis Business (2018-2023)
11.9.5 Anchor Dx Recent Developments
11.10 ANGLE plc
11.10.1 ANGLE plc Company Details
11.10.2 ANGLE plc Business Overview
11.10.3 ANGLE plc Cancer Genome Analysis Introduction
11.10.4 ANGLE plc Revenue in Cancer Genome Analysis Business (2018-2023)
11.10.5 ANGLE plc Recent Developments
11.11 ApoCell, Inc.
11.11.1 ApoCell, Inc. Company Details
11.11.2 ApoCell, Inc. Business Overview
11.11.3 ApoCell, Inc. Cancer Genome Analysis Introduction
11.11.4 ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2018-2023)
11.11.5 ApoCell, Inc. Recent Developments
11.12 ArcherDx, Inc
11.12.1 ArcherDx, Inc Company Details
11.12.2 ArcherDx, Inc Business Overview
11.12.3 ArcherDx, Inc Cancer Genome Analysis Introduction
11.12.4 ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.12.5 ArcherDx, Inc Recent Developments
11.13 Asuragen
11.13.1 Asuragen Company Details
11.13.2 Asuragen Business Overview
11.13.3 Asuragen Cancer Genome Analysis Introduction
11.13.4 Asuragen Revenue in Cancer Genome Analysis Business (2018-2023)
11.13.5 Asuragen Recent Developments
11.14 AVIVA Biosciences
11.14.1 AVIVA Biosciences Company Details
11.14.2 AVIVA Biosciences Business Overview
11.14.3 AVIVA Biosciences Cancer Genome Analysis Introduction
11.14.4 AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2018-2023)
11.14.5 AVIVA Biosciences Recent Developments
11.15 Baylor Miraca Genetics Laboratories
11.15.1 Baylor Miraca Genetics Laboratories Company Details
11.15.2 Baylor Miraca Genetics Laboratories Business Overview
11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Introduction
11.15.4 Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2018-2023)
11.15.5 Baylor Miraca Genetics Laboratories Recent Developments
11.16 Beckman Coulter, Inc.
11.16.1 Beckman Coulter, Inc. Company Details
11.16.2 Beckman Coulter, Inc. Business Overview
11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Introduction
11.16.4 Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2018-2023)
11.16.5 Beckman Coulter, Inc. Recent Developments
11.17 Becton, Dickinson and Company
11.17.1 Becton, Dickinson and Company Company Details
11.17.2 Becton, Dickinson and Company Business Overview
11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Introduction
11.17.4 Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2018-2023)
11.17.5 Becton, Dickinson and Company Recent Developments
11.18 BGI Genomics Co. Ltd
11.18.1 BGI Genomics Co. Ltd Company Details
11.18.2 BGI Genomics Co. Ltd Business Overview
11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Introduction
11.18.4 BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2018-2023)
11.18.5 BGI Genomics Co. Ltd Recent Developments
11.19 Bioarray Genetics
11.19.1 Bioarray Genetics Company Details
11.19.2 Bioarray Genetics Business Overview
11.19.3 Bioarray Genetics Cancer Genome Analysis Introduction
11.19.4 Bioarray Genetics Revenue in Cancer Genome Analysis Business (2018-2023)
11.19.5 Bioarray Genetics Recent Developments
11.20 Biocartis
11.20.1 Biocartis Company Details
11.20.2 Biocartis Business Overview
11.20.3 Biocartis Cancer Genome Analysis Introduction
11.20.4 Biocartis Revenue in Cancer Genome Analysis Business (2018-2023)
11.20.5 Biocartis Recent Developments
11.21 Biocept, Inc
11.21.1 Biocept, Inc Company Details
11.21.2 Biocept, Inc Business Overview
11.21.3 Biocept, Inc Cancer Genome Analysis Introduction
11.21.4 Biocept, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.21.5 Biocept, Inc Recent Developments
11.22 Biodesix Inc
11.22.1 Biodesix Inc Company Details
11.22.2 Biodesix Inc Business Overview
11.22.3 Biodesix Inc Cancer Genome Analysis Introduction
11.22.4 Biodesix Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.22.5 Biodesix Inc Recent Developments
11.23 BioFluidica
11.23.1 BioFluidica Company Details
11.23.2 BioFluidica Business Overview
11.23.3 BioFluidica Cancer Genome Analysis Introduction
11.23.4 BioFluidica Revenue in Cancer Genome Analysis Business (2018-2023)
11.23.5 BioFluidica Recent Developments
11.24 bioMйrieux Diagnostics
11.24.1 bioMйrieux Diagnostics Company Details
11.24.2 bioMйrieux Diagnostics Business Overview
11.24.3 bioMйrieux Diagnostics Cancer Genome Analysis Introduction
11.24.4 bioMйrieux Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023)
11.24.5 bioMйrieux Diagnostics Recent Developments
11.25 Bioneer Corporation
11.25.1 Bioneer Corporation Company Details
11.25.2 Bioneer Corporation Business Overview
11.25.3 Bioneer Corporation Cancer Genome Analysis Introduction
11.25.4 Bioneer Corporation Revenue in Cancer Genome Analysis Business (2018-2023)
11.25.5 Bioneer Corporation Recent Developments
11.26 Bio-Rad Laboratories, Inc
11.26.1 Bio-Rad Laboratories, Inc Company Details
11.26.2 Bio-Rad Laboratories, Inc Business Overview
11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Introduction
11.26.4 Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2018-2023)
11.26.5 Bio-Rad Laboratories, Inc Recent Developments
11.27 Bio-Techne
11.27.1 Bio-Techne Company Details
11.27.2 Bio-Techne Business Overview
11.27.3 Bio-Techne Cancer Genome Analysis Introduction
11.27.4 Bio-Techne Revenue in Cancer Genome Analysis Business (2018-2023)
11.27.5 Bio-Techne Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cancer Genome Analysis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Solid Tissue Analysis
Table 3. Key Players of Liquid Tissue Analysis
Table 4. Global Cancer Genome Analysis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Cancer Genome Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cancer Genome Analysis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Genome Analysis Market Share by Region (2018-2023)
Table 8. Global Cancer Genome Analysis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cancer Genome Analysis Market Share by Region (2024-2029)
Table 10. Cancer Genome Analysis Market Trends
Table 11. Cancer Genome Analysis Market Drivers
Table 12. Cancer Genome Analysis Market Challenges
Table 13. Cancer Genome Analysis Market Restraints
Table 14. Global Cancer Genome Analysis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Genome Analysis Revenue Share by Players (2018-2023)
Table 16. Global Top Cancer Genome Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2022)
Table 17. Global Cancer Genome Analysis Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Cancer Genome Analysis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Cancer Genome Analysis, Headquarters and Area Served
Table 20. Global Key Players of Cancer Genome Analysis, Product and Application
Table 21. Global Key Players of Cancer Genome Analysis, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Genome Analysis Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Genome Analysis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cancer Genome Analysis Revenue Market Share by Type (2024-2029)
Table 27. Global Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Genome Analysis Revenue Share by Application (2018-2023)
Table 29. Global Cancer Genome Analysis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cancer Genome Analysis Revenue Share by Application (2024-2029)
Table 31. North America Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Cancer Genome Analysis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Cancer Genome Analysis Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Cancer Genome Analysis Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 63. Abbott Diagnostics Company Details
Table 64. Abbott Diagnostics Business Overview
Table 65. Abbott Diagnostics Cancer Genome Analysis Product
Table 66. Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 67. Abbott Diagnostics Recent Developments
Table 68. AccuraGen Inc Company Details
Table 69. AccuraGen Inc Business Overview
Table 70. AccuraGen Inc Cancer Genome Analysis Product
Table 71. AccuraGen Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 72. AccuraGen Inc Recent Developments
Table 73. Acuamark Diagnostics Company Details
Table 74. Acuamark Diagnostics Business Overview
Table 75. Acuamark Diagnostics Cancer Genome Analysis Product
Table 76. Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 77. Acuamark Diagnostics Recent Developments
Table 78. Admera Health, LLC Company Details
Table 79. Admera Health, LLC Business Overview
Table 80. Admera Health, LLC Cancer Genome Analysis Product
Table 81. Admera Health, LLC Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 82. Admera Health, LLC Recent Developments
Table 83. Agena Bioscience, Inc Company Details
Table 84. Agena Bioscience, Inc Business Overview
Table 85. Agena Bioscience, Inc Cancer Genome Analysis Product
Table 86. Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 87. Agena Bioscience, Inc Recent Developments
Table 88. Agilent Company Details
Table 89. Agilent Business Overview
Table 90. Agilent Cancer Genome Analysis Product
Table 91. Agilent Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 92. Agilent Recent Developments
Table 93. Almac Diagnostics Company Details
Table 94. Almac Diagnostics Business Overview
Table 95. Almac Diagnostics Cancer Genome Analysis Product
Table 96. Almac Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 97. Almac Diagnostics Recent Developments
Table 98. Amoy Diagnostics Co., Ltd. Company Details
Table 99. Amoy Diagnostics Co., Ltd. Business Overview
Table 100. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product
Table 101. Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 102. Amoy Diagnostics Co., Ltd. Recent Developments
Table 103. Anchor Dx Company Details
Table 104. Anchor Dx Business Overview
Table 105. Anchor Dx Cancer Genome Analysis Product
Table 106. Anchor Dx Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 107. Anchor Dx Recent Developments
Table 108. ANGLE plc Company Details
Table 109. ANGLE plc Business Overview
Table 110. ANGLE plc Cancer Genome Analysis Product
Table 111. ANGLE plc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 112. ANGLE plc Recent Developments
Table 113. ApoCell, Inc. Company Details
Table 114. ApoCell, Inc. Business Overview
Table 115. ApoCell, Inc. Cancer Genome Analysis Product
Table 116. ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 117. ApoCell, Inc. Recent Developments
Table 118. ArcherDx, Inc Company Details
Table 119. ArcherDx, Inc Business Overview
Table 120. ArcherDx, Inc Cancer Genome Analysis Product
Table 121. ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 122. ArcherDx, Inc Recent Developments
Table 123. Asuragen Company Details
Table 124. Asuragen Business Overview
Table 125. Asuragen Cancer Genome Analysis Product
Table 126. Asuragen Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 127. Asuragen Recent Developments
Table 128. AVIVA Biosciences Company Details
Table 129. AVIVA Biosciences Business Overview
Table 130. AVIVA Biosciences Cancer Genome Analysis Product
Table 131. AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 132. AVIVA Biosciences Recent Developments
Table 133. Baylor Miraca Genetics Laboratories Company Details
Table 134. Baylor Miraca Genetics Laboratories Business Overview
Table 135. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product
Table 136. Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 137. Baylor Miraca Genetics Laboratories Recent Developments
Table 138. Beckman Coulter, Inc. Company Details
Table 139. Beckman Coulter, Inc. Business Overview
Table 140. Beckman Coulter, Inc. Cancer Genome Analysis Product
Table 141. Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 142. Beckman Coulter, Inc. Recent Developments
Table 143. Becton, Dickinson and Company Company Details
Table 144. Becton, Dickinson and Company Business Overview
Table 145. Becton, Dickinson and Company Cancer Genome Analysis Product
Table 146. Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 147. Becton, Dickinson and Company Recent Developments
Table 148. BGI Genomics Co. Ltd Company Details
Table 149. BGI Genomics Co. Ltd Business Overview
Table 150. BGI Genomics Co. Ltd Cancer Genome Analysis Product
Table 151. BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 152. BGI Genomics Co. Ltd Recent Developments
Table 153. Bioarray Genetics Company Details
Table 154. Bioarray Genetics Business Overview
Table 155. Bioarray Genetics Cancer Genome Analysis Product
Table 156. Bioarray Genetics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 157. Bioarray Genetics Recent Developments
Table 158. Biocartis Company Details
Table 159. Biocartis Business Overview
Table 160. Biocartis Cancer Genome Analysis Product
Table 161. Biocartis Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 162. Biocartis Recent Developments
Table 163. Biocept, Inc Company Details
Table 164. Biocept, Inc Business Overview
Table 165. Biocept, Inc Cancer Genome Analysis Product
Table 166. Biocept, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 167. Biocept, Inc Recent Developments
Table 168. Biodesix Inc Company Details
Table 169. Biodesix Inc Business Overview
Table 170. Biodesix Inc Cancer Genome Analysis Product
Table 171. Biodesix Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 172. Biodesix Inc Recent Developments
Table 173. BioFluidica Company Details
Table 174. BioFluidica Business Overview
Table 175. BioFluidica Cancer Genome Analysis Product
Table 176. BioFluidica Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 177. BioFluidica Recent Developments
Table 178. bioMйrieux Diagnostics Company Details
Table 179. bioMйrieux Diagnostics Business Overview
Table 180. bioMйrieux Diagnostics Cancer Genome Analysis Product
Table 181. bioMйrieux Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 182. bioMйrieux Diagnostics Recent Developments
Table 183. Bioneer Corporation Company Details
Table 184. Bioneer Corporation Business Overview
Table 185. Bioneer Corporation Cancer Genome Analysis Product
Table 186. Bioneer Corporation Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 187. Bioneer Corporation Recent Developments
Table 188. Bio-Rad Laboratories, Inc Company Details
Table 189. Bio-Rad Laboratories, Inc Business Overview
Table 190. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product
Table 191. Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 192. Bio-Rad Laboratories, Inc Recent Developments
Table 193. Bio-Techne Company Details
Table 194. Bio-Techne Business Overview
Table 195. Bio-Techne Cancer Genome Analysis Product
Table 196. Bio-Techne Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 197. Bio-Techne Recent Developments
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 1. Global Cancer Genome Analysis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Solid Tissue Analysis
Table 3. Key Players of Liquid Tissue Analysis
Table 4. Global Cancer Genome Analysis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Cancer Genome Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cancer Genome Analysis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Genome Analysis Market Share by Region (2018-2023)
Table 8. Global Cancer Genome Analysis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cancer Genome Analysis Market Share by Region (2024-2029)
Table 10. Cancer Genome Analysis Market Trends
Table 11. Cancer Genome Analysis Market Drivers
Table 12. Cancer Genome Analysis Market Challenges
Table 13. Cancer Genome Analysis Market Restraints
Table 14. Global Cancer Genome Analysis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Genome Analysis Revenue Share by Players (2018-2023)
Table 16. Global Top Cancer Genome Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2022)
Table 17. Global Cancer Genome Analysis Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Cancer Genome Analysis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Cancer Genome Analysis, Headquarters and Area Served
Table 20. Global Key Players of Cancer Genome Analysis, Product and Application
Table 21. Global Key Players of Cancer Genome Analysis, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Genome Analysis Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Genome Analysis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cancer Genome Analysis Revenue Market Share by Type (2024-2029)
Table 27. Global Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Genome Analysis Revenue Share by Application (2018-2023)
Table 29. Global Cancer Genome Analysis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cancer Genome Analysis Revenue Share by Application (2024-2029)
Table 31. North America Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Cancer Genome Analysis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Cancer Genome Analysis Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Cancer Genome Analysis Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Genome Analysis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size by Country (2024-2029) & (US$ Million)
Table 63. Abbott Diagnostics Company Details
Table 64. Abbott Diagnostics Business Overview
Table 65. Abbott Diagnostics Cancer Genome Analysis Product
Table 66. Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 67. Abbott Diagnostics Recent Developments
Table 68. AccuraGen Inc Company Details
Table 69. AccuraGen Inc Business Overview
Table 70. AccuraGen Inc Cancer Genome Analysis Product
Table 71. AccuraGen Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 72. AccuraGen Inc Recent Developments
Table 73. Acuamark Diagnostics Company Details
Table 74. Acuamark Diagnostics Business Overview
Table 75. Acuamark Diagnostics Cancer Genome Analysis Product
Table 76. Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 77. Acuamark Diagnostics Recent Developments
Table 78. Admera Health, LLC Company Details
Table 79. Admera Health, LLC Business Overview
Table 80. Admera Health, LLC Cancer Genome Analysis Product
Table 81. Admera Health, LLC Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 82. Admera Health, LLC Recent Developments
Table 83. Agena Bioscience, Inc Company Details
Table 84. Agena Bioscience, Inc Business Overview
Table 85. Agena Bioscience, Inc Cancer Genome Analysis Product
Table 86. Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 87. Agena Bioscience, Inc Recent Developments
Table 88. Agilent Company Details
Table 89. Agilent Business Overview
Table 90. Agilent Cancer Genome Analysis Product
Table 91. Agilent Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 92. Agilent Recent Developments
Table 93. Almac Diagnostics Company Details
Table 94. Almac Diagnostics Business Overview
Table 95. Almac Diagnostics Cancer Genome Analysis Product
Table 96. Almac Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 97. Almac Diagnostics Recent Developments
Table 98. Amoy Diagnostics Co., Ltd. Company Details
Table 99. Amoy Diagnostics Co., Ltd. Business Overview
Table 100. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product
Table 101. Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 102. Amoy Diagnostics Co., Ltd. Recent Developments
Table 103. Anchor Dx Company Details
Table 104. Anchor Dx Business Overview
Table 105. Anchor Dx Cancer Genome Analysis Product
Table 106. Anchor Dx Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 107. Anchor Dx Recent Developments
Table 108. ANGLE plc Company Details
Table 109. ANGLE plc Business Overview
Table 110. ANGLE plc Cancer Genome Analysis Product
Table 111. ANGLE plc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 112. ANGLE plc Recent Developments
Table 113. ApoCell, Inc. Company Details
Table 114. ApoCell, Inc. Business Overview
Table 115. ApoCell, Inc. Cancer Genome Analysis Product
Table 116. ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 117. ApoCell, Inc. Recent Developments
Table 118. ArcherDx, Inc Company Details
Table 119. ArcherDx, Inc Business Overview
Table 120. ArcherDx, Inc Cancer Genome Analysis Product
Table 121. ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 122. ArcherDx, Inc Recent Developments
Table 123. Asuragen Company Details
Table 124. Asuragen Business Overview
Table 125. Asuragen Cancer Genome Analysis Product
Table 126. Asuragen Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 127. Asuragen Recent Developments
Table 128. AVIVA Biosciences Company Details
Table 129. AVIVA Biosciences Business Overview
Table 130. AVIVA Biosciences Cancer Genome Analysis Product
Table 131. AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 132. AVIVA Biosciences Recent Developments
Table 133. Baylor Miraca Genetics Laboratories Company Details
Table 134. Baylor Miraca Genetics Laboratories Business Overview
Table 135. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product
Table 136. Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 137. Baylor Miraca Genetics Laboratories Recent Developments
Table 138. Beckman Coulter, Inc. Company Details
Table 139. Beckman Coulter, Inc. Business Overview
Table 140. Beckman Coulter, Inc. Cancer Genome Analysis Product
Table 141. Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 142. Beckman Coulter, Inc. Recent Developments
Table 143. Becton, Dickinson and Company Company Details
Table 144. Becton, Dickinson and Company Business Overview
Table 145. Becton, Dickinson and Company Cancer Genome Analysis Product
Table 146. Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 147. Becton, Dickinson and Company Recent Developments
Table 148. BGI Genomics Co. Ltd Company Details
Table 149. BGI Genomics Co. Ltd Business Overview
Table 150. BGI Genomics Co. Ltd Cancer Genome Analysis Product
Table 151. BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 152. BGI Genomics Co. Ltd Recent Developments
Table 153. Bioarray Genetics Company Details
Table 154. Bioarray Genetics Business Overview
Table 155. Bioarray Genetics Cancer Genome Analysis Product
Table 156. Bioarray Genetics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 157. Bioarray Genetics Recent Developments
Table 158. Biocartis Company Details
Table 159. Biocartis Business Overview
Table 160. Biocartis Cancer Genome Analysis Product
Table 161. Biocartis Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 162. Biocartis Recent Developments
Table 163. Biocept, Inc Company Details
Table 164. Biocept, Inc Business Overview
Table 165. Biocept, Inc Cancer Genome Analysis Product
Table 166. Biocept, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 167. Biocept, Inc Recent Developments
Table 168. Biodesix Inc Company Details
Table 169. Biodesix Inc Business Overview
Table 170. Biodesix Inc Cancer Genome Analysis Product
Table 171. Biodesix Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 172. Biodesix Inc Recent Developments
Table 173. BioFluidica Company Details
Table 174. BioFluidica Business Overview
Table 175. BioFluidica Cancer Genome Analysis Product
Table 176. BioFluidica Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 177. BioFluidica Recent Developments
Table 178. bioMйrieux Diagnostics Company Details
Table 179. bioMйrieux Diagnostics Business Overview
Table 180. bioMйrieux Diagnostics Cancer Genome Analysis Product
Table 181. bioMйrieux Diagnostics Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 182. bioMйrieux Diagnostics Recent Developments
Table 183. Bioneer Corporation Company Details
Table 184. Bioneer Corporation Business Overview
Table 185. Bioneer Corporation Cancer Genome Analysis Product
Table 186. Bioneer Corporation Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 187. Bioneer Corporation Recent Developments
Table 188. Bio-Rad Laboratories, Inc Company Details
Table 189. Bio-Rad Laboratories, Inc Business Overview
Table 190. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product
Table 191. Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 192. Bio-Rad Laboratories, Inc Recent Developments
Table 193. Bio-Techne Company Details
Table 194. Bio-Techne Business Overview
Table 195. Bio-Techne Cancer Genome Analysis Product
Table 196. Bio-Techne Revenue in Cancer Genome Analysis Business (2018-2023) & (US$ Million)
Table 197. Bio-Techne Recent Developments
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cancer Genome Analysis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Genome Analysis Market Share by Type: 2022 VS 2029
Figure 3. Solid Tissue Analysis Features
Figure 4. Liquid Tissue Analysis Features
Figure 5. Global Cancer Genome Analysis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Cancer Genome Analysis Market Share by Application: 2022 VS 2029
Figure 7. Clinical Case Studies
Figure 8. Pharmaceutical Case Studies
Figure 9. Research Case Studies
Figure 10. Cancer Genome Analysis Report Years Considered
Figure 11. Global Cancer Genome Analysis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Cancer Genome Analysis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cancer Genome Analysis Market Share by Region: 2022 VS 2029
Figure 14. Global Cancer Genome Analysis Market Share by Players in 2022
Figure 15. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2022
Figure 17. North America Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 19. North America Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 20. North America Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 21. United States Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 25. Europe Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 26. Europe Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 27. Germany Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 35. China Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 36. Asia Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 38. Asia Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 39. Asia Cancer Genome Analysis Market Share by Region (2018-2029)
Figure 40. Japan Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 50. Brazil Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Abbott Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 57. AccuraGen Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 58. Acuamark Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 59. Admera Health, LLC Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 60. Agena Bioscience, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 61. Agilent Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 62. Almac Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 63. Amoy Diagnostics Co., Ltd. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 64. Anchor Dx Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 65. ANGLE plc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 66. ApoCell, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 67. ArcherDx, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 68. Asuragen Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 69. AVIVA Biosciences Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 70. Baylor Miraca Genetics Laboratories Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 71. Beckman Coulter, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 72. Becton, Dickinson and Company Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 73. BGI Genomics Co. Ltd Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 74. Bioarray Genetics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 75. Biocartis Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 76. Biocept, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 77. Biodesix Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 78. BioFluidica Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 79. bioMйrieux Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 80. Bioneer Corporation Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 81. Bio-Rad Laboratories, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 82. Bio-Techne Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Figure 1. Global Cancer Genome Analysis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Genome Analysis Market Share by Type: 2022 VS 2029
Figure 3. Solid Tissue Analysis Features
Figure 4. Liquid Tissue Analysis Features
Figure 5. Global Cancer Genome Analysis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Cancer Genome Analysis Market Share by Application: 2022 VS 2029
Figure 7. Clinical Case Studies
Figure 8. Pharmaceutical Case Studies
Figure 9. Research Case Studies
Figure 10. Cancer Genome Analysis Report Years Considered
Figure 11. Global Cancer Genome Analysis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Cancer Genome Analysis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cancer Genome Analysis Market Share by Region: 2022 VS 2029
Figure 14. Global Cancer Genome Analysis Market Share by Players in 2022
Figure 15. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2022
Figure 17. North America Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 19. North America Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 20. North America Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 21. United States Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 25. Europe Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 26. Europe Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 27. Germany Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 35. China Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 36. Asia Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 38. Asia Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 39. Asia Cancer Genome Analysis Market Share by Region (2018-2029)
Figure 40. Japan Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Cancer Genome Analysis Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cancer Genome Analysis Market Share by Country (2018-2029)
Figure 50. Brazil Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Cancer Genome Analysis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Abbott Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 57. AccuraGen Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 58. Acuamark Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 59. Admera Health, LLC Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 60. Agena Bioscience, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 61. Agilent Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 62. Almac Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 63. Amoy Diagnostics Co., Ltd. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 64. Anchor Dx Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 65. ANGLE plc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 66. ApoCell, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 67. ArcherDx, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 68. Asuragen Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 69. AVIVA Biosciences Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 70. Baylor Miraca Genetics Laboratories Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 71. Beckman Coulter, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 72. Becton, Dickinson and Company Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 73. BGI Genomics Co. Ltd Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 74. Bioarray Genetics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 75. Biocartis Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 76. Biocept, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 77. Biodesix Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 78. BioFluidica Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 79. bioMйrieux Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 80. Bioneer Corporation Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 81. Bio-Rad Laboratories, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 82. Bio-Techne Revenue Growth Rate in Cancer Genome Analysis Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
